Online HML - June 2022


You are viewing June 2022. View May 2022 Schedule.

Programmed Cell Death-1 (PD-1) Inhibitors
Nivolumab Inj 10 mg per ml, 4 ml vial; Inj 10 mg per ml, 10 ml vial
Pembrolizumab Inj 25 mg per ml, 4 ml vial